Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy

Journal of Gastrointestinal Surgery

Volumn 13, Issue 2, 2009, Pages 325-333

  Mizuguchi, Toru ^a   Nagayama, Minoru ^a   Meguro, Makoto ^a   Shibata, Toshihito ^a   Kaji, Shinsuke ^a   Nobuoka, Takayuki ^a   Kimura, Yasutoshi ^a   Furuhata, Tomohisa ^a   Hirata, Koichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Complication; Hepatectomy; Hepatocellular carcinoma; Hepatocyte growth factor; Prognosis

Indexed keywords

SCATTER FACTOR;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; RISK FACTOR; ROC CURVE; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 59149098933     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0711-8     Document Type: Article

References (22)

1. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 doi:10.1056/NEJM199903113401001
2. JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 1917 doi:10.1016/S0140-6736(03)14964-1
3. PD Schneider 2004 Preoperative assessment of liver function Surg Clin North Am 84 355 373 doi:10.1016/S0039-6109(03)00224-X
4. AH Kwon SK Ha-Kawa S Uetsuji Y Kamiyama Y Tanaka 1995 Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy Surgery 117 429 434 doi:10.1016/S0039- 6060(05)80063-7
5. T Mizuguchi T Katsuramaki T Nobuoka M Kawamoto H Oshima H Kawasaki 2004 Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy World J Surg 28 971 976 doi:10.1007/s00268-004-7389-1
6. JN Vauthey TM Pawlik EK Abdalla JF Arens RA Nemr SH Wei 2004 Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239 722 730 doi:10.1097/01.sla.0000124385.83887.d5
7. RT Poon ST Fan CM Lo CL Liu CM Lam WK Yuen 2004 Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database Ann Surg 240 698 708 doi:10.1097/01.sla.0000143808.63039.51
8. G Shiota J Okano H Kawasaki T Kawamoto T Nakamura 1995 Serum hepatocyte growth factor levels in liver diseases: clinical implications Hepatology 21 106 112
9. H Yamagamim M Moriyama H Matsumura H Aoki T Shimizu T Saito 2002 Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases Cancer 95 824 834 doi:10.1002/cncr.10732
10. I Ikai S Arii M Kojiro T Ichida M Makuuchi Y Matsuyama 2004 Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey Cancer 101 796 802 doi:10.1002/cncr.20426
11. M Kaibori Y Matsui T Hijikawa Y Uchida AH Kwon Y Kamiyama 2006 Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C Surgery 139 385 394 doi:10.1016/j.surg.2005.08.035
12. E Gohda H Tsubouchi H Nakayama S Hirono K Takahashi M Koura 1986 Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure Exp Cell Res 166 139 150 doi:10.1016/0014-4827(86)90514-8
13. K Breuhahn T Longerich P Schirmacher 2006 Dysregulation of growth factor signaling in human hepatocellular carcinoma Oncogene 25 3787 3800 doi:10.1038/sj.onc.1209556
14. D Dindo N Demartines PA Clavien 2004 Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 205 213 doi:10.1097/01.sla.0000133083.54934.ae
15. RT Poon ST Fan 2004 Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome Liver Transpl 10 S39 S45 doi:10.1002/lt.20040
16. JM Llovet M Schwartz V Mazzaferro 2005 Resection and liver transplantation for hepatocellular carcinoma Semin Liver Dis 25 181 200 doi:10.1055/s-2005-871198
17. RC Martin 2nd MF Brennan DP Jaques 2002 Quality of complication reporting in the surgical literature Ann Surg 235 803 813 doi:10.1097/00000658-200206000- 00007
18. WR Jarnagin M Gonen Y Fong RP DeMatteo L Ben-Porat S Little 2002 Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade Ann Surg 236 397 406 doi:10.1097/ 00000658-200210000-00001
19. B Pol P Campan J Hardwigsen G Botti J Pons YP Le Treut 1999 Morbidity of major hepatic resections: a 100-case prospective study Eur J Surg 165 446 453 doi:10.1080/110241599750006686
20. CG Huh VM Factor A Sanchez K Uchida EA Conner SS Thorgeirsson 2004 Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair Proc Natl Acad Sci U S A 101 4477 4482 doi:10.1073/pnas.0306068101
21. A D'Errico M Fiorentino A Ponzetto Y Daikuhara H Tsubouchi C Brechot 1996 Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does Hepatology 24 60 64
22. N Arakaki S Kawakami O Nakamura T Ohnishi H Miyazaki T Ishii 1995 Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases Hepatology 22 1728 1734